AMETEK Shares Rise on Upgraded Earnings Outlook as Baxter Edges Lower

Key Facts

1AMETEK stock rose 1.38% to EUR 224.60 following an increased 2026 diluted EPS outlook to $8.20-$8.30.

2Baxter International stock declined 0.95% to EUR 20.82 as the company released its 2026 Connected Hospital Report.

AMETEK stock rose 1.38% to EUR 224.60 in after-hours trading after the company increased its 2026 diluted earnings per share outlook. AD HOC NEWS reported that management now projects EPS between $8.20 and $8.30, up from the previous range of $7.94 to $8.14. Meanwhile, Baxter International shares declined 0.95% to EUR 20.82 as the company released its 2026 Connected Hospital Report.

AMETEK achieved record second-quarter sales of $2.04 billion, a 15% increase year-over-year, while orders reached a record $2.3 billion. AME closed at $249.09 on October 1, 2026, and BAX closed at $23.64 on the same date. According to company data, diluted second-quarter earnings per share reached $2.09, up 17% from the prior year, supported by a backlog of $4.11 billion.